Kevin Sule
Equity Analyst, Redeye
Replay available
IRLAB Therapeutics AB (publ) (IRLAB_A) Q1 2025 Earnings Call
IRLAB Therapeutics AB (publ) (STO: IRLAB_A) Q1 2025 earnings conference call, held 2025-05-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Kristina Torfgaard
CEO
Niklas Waters
Executive Vice President Research and Development
Viktor Sivic
CFO
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Irlab Therapeutics Ab Class A.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.419 Welcome to this live broadcasted Q1 presentation by research company 00:00:05.419 -- 00:00:07.582 IRLAB Therapeutics. 00:00:07.582 -- 00:00:12.830 Presenting today is CEO Kristina Torfgaard, Executive Vice President Research 00:00:12.830 -- 00:00:18.078 and Development Niklas Waters and CFO Viktor Sivic. 00:00:18.078 -- 00:00:23.446 After the presentation there will be a Q&A session with equity analysts 00:00:23.446 -- 00:00:27.773 and viewers can ask their questions in the live chat. 00:00:27.773 -- 00:00:31.597 Hello and welcome, Kristina Torfgård. 00:00:31.597 -- 00:00:34.279 Hello and thank you very much. 00:00:34.279 -- 00:00:39.024 So please go ahead with your presentation and I'll be back for the Q&A. 00:00:39.024 -- 00:00:44.390 Sure, thanks. So first of all, on behalf of iLab, I would like to welcome 00:00:44.390 -- 00:00:50.676 everyone to today's webcast where we are going to present the Q1 report. 00:00:50.676 -- 00:00:55.140 And if we start with the slides, please. 00:00:55.140 -- 00:00:57.490 And the next one. 00:00:57.490 -- 00:01:00.893 is our disclaimers, and then we have the agenda. 00:01:00.893 -- 00:01:06.359 Next one. So I will start and take you through the news of the period. 00:01:06.359 -- 00:01:11.604 After that, I will hand over to Nicholas Waters to take you through the R&D 00:01:11.604 -- 00:01:16.869 update. And this will be followed by a financial update by Victor 00:01:16.869 -- 00:01:22.094 Sievert. And I will then make a concluding words, and then 00:01:22.094 -- 00:01:25.377 we will start off the Q&A session. 00:01:25.377 -- 00:01:28.017 So the next slide, please. 00:01:28.017 -- 00:01:31.900 I would like to remind everyone and start with this slide. 00:01:31.900 -- 00:01:33.702 And 00:01:33.702 -...